4//SEC Filing
KELLY JUSTYNA 4
Accession 0001209191-21-068950
CIK 0001811764other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 11:27 AM ET
Size
5.6 KB
Accession
0001209191-21-068950
Insider Transaction Report
Form 4
KELLY JUSTYNA
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-09+70,000→ 70,000 totalExercise: $6.40Exp: 2027-12-09→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on December 9, 2022 with the remaining 75% vesting in three equal annual installments thereafter. Notwithstanding the foregoing, upon any Sale Event (as defined in the Issuer's 2021 Plan), any outstanding stock options shall automatically become fully vested and exercisable as of the effective time of the Sale Event.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001898344
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 11:27 AM ET
- Size
- 5.6 KB